Summary: Paclitaxel (Taxol - Bristol-Myers Squibb) is the first of a new group of cytotoxic drugs, the taxanes. It is licensed for the treatment of patients with metastatic ovarian carcinoma \\\"where standard, platinum-containing, therapy has failed\\\". What is its place in treatment?

No Comments Found